Out paper has just been posted by @ofidjournal.bsky.social! 🎉 #TxID #HSCT #BMT #IDSKy#InfectiousDiseases @hermesrh.bsky.social

Effect of quinolone prophylaxis discontinuation during pre-engraftment neutropenia on incidence, mortality, and aetiology of bloodstream infections in hematopoietic stem-cell transplant recipients: a systematic review and meta-analysis ✅ Just Accepted 🔗 https://bit.ly/4eJrdDB

🎉 Excited to share that our new paper has been published in OFID! Many thanks to all co-authors and collaborators who contributed to this work! 🙌 @ofidjournal.bsky.social @hermesrh.bsky.social #HSCT #BMT #TxID #IDSky academic.oup.com/ofid/article...

🆕💥🟢Systematic review and meta-analysis Discontinuation of quinolone prophylaxis during pre-engraftment neutropenia was associated with an elevated incidence of BSIs* in hematopoietic stem-cell transplant recipients #idsky academic.oup.com/ofid/article...

The fine balance of prophylactic antibiotics. Prevent infections but are these infections significant and at what cost (resistance)? Here in stem cell transplants, but also relevant to other settings #IDSky #UTISky #AMR #ClinMicro academic.oup.com/ofid/advance...

Many have wanted the data - and the final publication for the Nitazoxanide for Norovirus in Transplants Study is out! Time to stop using nitazoxanide for norovirus - zero impact on virology, no impact on clinical outcomes and clear financial toxicity. pubmed.ncbi.nlm.nih.gov/42177030/

First reported case of paracoccidioidomycosis after HSCT in a patient with chronic GVHD 🧬🦠🍄 Rare, but clinically relevant in endemic settings — keep it on the radar 🌎 Presented at ESCMID Global 2026 🇩🇪 #ESCMIDGlobal2026 #HSCT #InfectiousDiseases #Mycology

Happy to share our work at #ESCMIDGlobal2026 ! 🇩🇪 #HSCT #TxID #IDSky

IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal COVID-19 infections in immunocompromised patients ✅ Just Accepted 🔗 https://bit.ly/47FAtok

Legionella Pneumonia in the Modern Era: Clinical Features and Predictors of Mortality ✅ Just Accepted 🔗 https://bit.ly/4leAFQY

In the ESCUDDO trial, one dose of an HPV vaccine was noninferior to two doses in preventing HPV type 16 or 18 infection. Full trial results and Research Summary: nej.md/49OEzg1   #MedSky #IDSky

Great event at the XIX Course on Infections in Immunocompromised Patients – HCFMUSP! I had the opportunity to give an update on CMV in the context of HSCT #HSCT #BMT #IDSky #TxID

New #IDSAGuidelines! IDSA has released updated evidence-based recommendations on administering age-appropriate Influenza and RSV vaccinations in populations with compromised immunity. https://www.idsociety.org/Seasonal-RTI-Vaccinations-in-Immunocompromised-Patients/

Empirical antifungal treatment of critically ill patients with influenza-associated acute respiratory distress syndrome: A propensity score weighted observational study ✅ Just Accepted #IDSky

🚨 Preliminary results! 🚨 Our systematic review & meta-analysis on stopping quinolone prophylaxis pre-engraftment in HSCT — just presented at the XXIV Brazilian Congress of Infectious Diseases. #HSCT 🧬 #InfectiousDiseases 🌍 #BMT 💉 #IDSky 🌌 #TxID

Outstanding talk by @jobadd.bsky.social at the XXIV Brazilian Congress of Infectious Diseases on invasive fungal infections in solid organ transplantation! #IDSky #TxID #InfectiousDiseases

Do AMS really work in transplant units and what is yet to be done? Happy to share our systematic review in @eclinicalmed.bsky.social which we hope will support AB stewardship implementation in SOT units and future research steps #AMSsky #TxID #IDsky kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...

🎙️ Just published a new #Communicable episode: Communicable E28: Late-breaker trials at ESCMID Global: Should they change ... Hosted by Josh Davis @gurujosh.bsky.social Erin McCreary @erinmccreary.bsky.social Emily McDonald @dremilymcd.bsky.social Listen here: #IDSky #Clinmicro #MedSky

【Hepatic Mucormycosis】 Excited to share our latest review on hepatic mucormycosis! 👉N=40, 1990-2025 👉histopathology (73%), culture positivity was low (36%) Big congratulations to Hazim for leading the effort! @mdanderson.bsky.social @msgerc.bsky.social www.mdpi.com/2309-608X/11...

Can we safely proceed with HSCT after COVID-19? 🤔🧬 Our new study says yes ✅ — overall survival is unchanged. But ⚠️ the risk of acute GVHD is significantly higher in patients with prior COVID-19 😷➡️🧫 📄 Read more: doi.org/10.1038/s414... #HSCT #COVID19 #GVHD #InfectiousDiseases #BMT #IDSky #TxID

Updated #IDSAGuidelines! IDSA Guidelines on Histoplasmosis Treatment: Focused Update on Asymptomatic Histoplasma Pulmonary Nodules and Mild or Moderate Acute Pulmonary Histoplasmosis are out now: buff.ly/vHZV7YQ

We previously reported a case of fatal hepatic mucormycosis after Haplo-HSCT ⚠️ Hepatic abscess - sequencing: Mucor indicus 💉 Early liposomal amphotericin B wasn't enough 📉 Literature review: 24 cases; 50.0% multiple lesions; mortality rate 45.8% Full text: www.jiac-j.com/article/S134... #IDSky #TxID

Scientific Integrity Under Threat: The Role of the @idsainfo.bsky.social @pidsociety.bsky.social and @sheaepi.bsky.social Journals in an Evolving Political Landscape

Excited to share the updated CDC yellow book chapter on Immunocompromised Host and travel, here is the official updated website from the CDC. Let me know if you have questions or comments. www.cdc.gov/yellow-book/...

Blood virome after allogeneic hematopoietic stem cell transplantation ✅ Just Accepted #IDSky

🚨 Measles cases are rising — stay alert, especially for immunocompromised patients. Our group published data showing MMR after HSCT may be safe from 12 months post-Tx (if no GVHD or immunosuppression). 📰 Full article: pmc.ncbi.nlm.nih.gov/articles/PMC... #Measles #MMR #Vaccination #HSCT #IDSky

A true master class on Chagas in transplantation - emerging data supports the safety of using Chagas positive donors with careful monitoring and treatment. Marcelo Radisic #ESCMIDGlobal

One week left to register for this exclusive global health session featuring leading experts reviewing the latest developments in diagnostics, treatment strategies, and challenges in immunocompromised populations. Register Here: www.ichs.org/event-6069138